HomePIRS • NASDAQ
Follow
Pieris Pharmaceuticals Inc
Previous close
$0.19
Day range
$0.18 - $0.19
Year range
$0.14 - $1.29
Market cap
18.46M USD
Avg Volume
919.53K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | 19.52M | 263.50% |
Operating expense | 6.84M | 73.18% |
Net income | -10.75M | -10.44% |
Net profit margin | -55.08 | 69.62% |
Earnings per share | -0.11 | 15.38% |
EBITDA | 3.82M | 133.55% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 44.81M | -35.82% |
Total assets | 59.38M | -40.12% |
Total liabilities | 28.87M | -54.47% |
Total equity | 30.51M | — |
Shares outstanding | 98.85M | — |
Price to book | 0.62 | — |
Return on assets | 10.50% | — |
Return on capital | 16.05% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -10.75M | -10.44% |
Cash from operations | -9.72M | -10.77% |
Cash from investing | -1.98M | -136.27% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -12.04M | -106.44% |
Free cash flow | -16.97M | -123.91% |
About
Founded
2000
Headquarters
Website
Employees
136